• About CSC
• Our Science
• Products
• Education
• Partnerships
• News and Events

California Stem Cell is focused on the production and supply of clinically relevant human cell populations, and their therapeutic application to human disease and injury.

California Stem Cell (CSC) is a privately held company focused on the manufacturing of high-purity human cells for therapeutic development and clinical application.

Since its founding in 2005, CSC has developed proprietary methods for scalable production of human motor neurons, neuronal progenitors, cardiac muscle and sino-atrial node cells, at high purity, from hESCs. We can generate virtually unlimited quantities of differentiated human cells in an FDA-compliant manner that renders these populations clinically relevant.

CSC is currently in the pre-clinical development stage of stem cell based therapies for amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease), spinal muscular atrophy (SMA), spinal cord injury (SCI) and coronary heart disease.

CSC also markets our high-purity human cells in platforms suitable for high throughput and high content screening of conventional drug candidates using human cell substrates, predictive toxicity of conventional drugs using human cell substrates, and development of experimental research tools.

FDA APPROVES WORLD'S FIRST EMBRYONIC STEM CELL THERAPY, BASED ON TECHNOLOGY INVENTED AND CO-DEVELOPED BY CSC SCIENTIFIC ADVISORY BOARD MEMBERS HANS KEIRSTEAD AND GABRIEL NISTOR

Meet Our Team

CIRMTV Goes Live!

CSC Scientific Advisory Board Chairman, Hans Keirstead, discusses the state of the field.
Watch now

Live Cells on Demand!

California Stem Cell is now shipping high purity populations of fully characterized hESC-derived human cells in an ideal format for drug screening and predictive toxicology.
Learn more